Nexviazyme

Amicus Therapeutics

Pharma

FDA OKs Amicus Pompe combo, setting up market battle with Sanofi

Amicus has gained a long-awaited FDA green light for its Pompe disease combination treatment combo of Pombiliti and Opfolda.

Kevin Dunleavy Sep 28, 2023 3:15pm

Traffic light go start restart green light

Amicus' Pompe approval portends a showdown with Sanofi

Mar 28, 2023 10:25am

Sanofi Cambridge

Europe endorses two Sanofi enzyme replacement therapies

Jun 28, 2022 11:21am